← signals
2026-07-05·TSM·market sentiment shift
lowup

Multiple Manifold prediction markets indicate high confidence in TSMC's market cap reaching $1 trillion by 2025 (99%)...

Multiple Manifold prediction markets indicate high confidence in TSMC's market cap reaching $1 trillion by 2025 (99%) and by 2026 (94.72%), and even $2 trillion by 2026 (76.41%). These probabilities suggest strong bullish sentiment about TSMC's future valuation, likely driven by AI chip demand. However, these are speculative markets, not official company guidance. What the sources said: - Source 12: "Will TSMC have a market cap of $1 trillion or more at the end of 2025? YES=99.00%" Manifold - Source 2: "Will TSMC have a market cap of $1 trillion or more at the end of 2026? YES=94.72%" Manifold - Source 3: "Will TSMC have a market cap of $2 trillion or more at the end of 2026? YES=76.41%" Manifold

window 60devidence 15confidence score 91price TSM $434.16

confidence score

Strong evidence: 1 independent source class support this read.

91
low confidence1 independent source classesmarketpasses publish gate
priced-in check

TSM has already moved up +28% over the recent 30-90 day window.

partly priced
as of 2026-07-027d n/a45d n/a90d +28%yahoo

signal brief

Multiple Manifold prediction markets indicate high confidence in TSMC's market cap reaching $1 trillion by 2025 (99%) and by 2026 (94.72%), and even $2 trillion by 2026 (76.41%). These probabilities suggest strong bullish sentiment about TSMC's future valuation, likely driven by AI chip demand. However, these are speculative markets, not official company guidance.

What the sources said:

  • Source 12: "Will TSMC have a market cap of $1 trillion or more at the end of 2025? YES=99.00%" Manifold
  • Source 2: "Will TSMC have a market cap of $1 trillion or more at the end of 2026? YES=94.72%" Manifold
  • Source 3: "Will TSMC have a market cap of $2 trillion or more at the end of 2026? YES=76.41%" Manifold

source data used

spillover entities

Decision support, not stock advice. This signal is research with cited evidence — not a recommendation to buy, sell, or hold any security.